논문KCI 등재
Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: Editorial on “High Steatosis-Associated Fibrosis Esti mator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-as sociated steatotic liver disease”
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
Can SAFE score be utilized as a universal hepatocellu lar carcinoma prediction score?: Editorial on “High Steatosis-Associated Fibrosis Estimator scores pre dict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated stea totic liver disease”Loey Lung-Yi Mak, Michael Kwan-Lung Ko대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Risk stratification of metabolic dysfunction-associated steatotic liver disease: The KASL pathway: Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”Jarell Jie-Rae Tan, May Xuan Goh, Vincent L Chen, Xin En Goh, Yu Jun Wong대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunc tion-associated steatotic liver disease”Hye Won Lee, Seung Up Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호HCC predictors in routine practice for patients with chronic liver diseases: Correspondence to editorial on “High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunc tion associated steatotic liver disease”Jia-Horng Kao, Tung-Hung Su대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Hai Xu, Huikun Wu, Yong Zhou대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”Keisuke Amano, Masahito Nakano, Takumi Kawaguchi, Toru Nakamura, Tsubasa Tsutsumi대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Mapp. 4-6Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12